|
|
Volumn 22, Issue 3, 2007, Pages 162-168
|
|
Development of a pharmacokinetic model to optimize the dosage regimen of TS-1, a combination preparation of tegafur, gimeracil and oteracil potassium.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 UFT PROTOCOL;
1-UFT PROTOCOL;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
FLUOROURACIL;
GIMERACIL;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
UNCLASSIFIED DRUG;
URACIL;
ALGORITHM;
AREA UNDER THE CURVE;
ARTICLE;
BIOLOGICAL MODEL;
BLOOD;
CLINICAL TRIAL;
COMPUTER SIMULATION;
DRUG COMBINATION;
HUMAN;
KIDNEY;
KIDNEY FAILURE;
KINETICS;
METABOLISM;
ORAL DRUG ADMINISTRATION;
TIME;
ADMINISTRATION, ORAL;
ALGORITHMS;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
COMPUTER SIMULATION;
DRUG COMBINATIONS;
FLUOROURACIL;
HUMANS;
KIDNEY;
KINETICS;
MODELS, BIOLOGICAL;
OXONIC ACID;
PYRIDINES;
RENAL INSUFFICIENCY;
TEGAFUR;
TIME FACTORS;
URACIL;
|
|
EID: 34548542077
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.22.162 Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
